Astrocytes in the glioblastoma tumor microenvironment.

Camilo Faust Akl, Brian M Andersen, Francisco J Quintana

Abstract read

In one paragraph

Article in Neuro-oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it

0cells of the map it votes in

0citing papers in PubMed

–field-weighted citation impact

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Camilo Faust AklAnn Romney Center for Neurologic Diseases, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachussetts, USA (C.F.A., B.M.A., F.J.Q.).

Brian M AndersenAnn Romney Center for Neurologic Diseases, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachussetts, USA (C.F.A., B.M.A., F.J.Q.).

Francisco J QuintanaAnn Romney Center for Neurologic Diseases, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachussetts, USA (C.F.A., B.M.A., F.J.Q.).

Funding

Cancer Neuroscience Training ProgramT32CA272386 · NCI · BRIGHAM AND WOMEN'S HOSPITAL · PI Tracy T Batchelor, MICHAEL ELDON GREENBERG · 2023 to 2026

$2.1M

American Cancer Society PA-1604-08459Biomedical Laboratory Research and DevelopmentCareer Enhancement ProgramGerman Academic Exchange ServiceInternational Progressive MS AllianceNCINCI NIH HHS T32 CA272386NIH HHS 1IK2BX006568-01A1NIH HHS AI126880NIH HHS ES02530NIH HHS ES029136NIH HHS JF2161-A-5NIH HHS NS102807NIH HHS RG4111A1NMSS RSG-14-198-01-LIBOffice of Research and DevelopmentPhRMA Foundation, Cancer Neuroscience T32CA272386Post-Doctoral Fellowship in Translational MedicineSPORE at Harvard Cancer Center P50CA165962Training Program in Nervous System Tumors K12CA090354VAVeterans Health Administration

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID41697355

DOI10.1093/neuonc/noaf191

PMCPMC12908412

What OpenQuestion holds

Textmetadata

LicenceCC BY

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.